Biogen, Ionis Spinal Muscular Atrophy Therapy Meets Study Goal
Biogen, Ionis Spinal Muscular Atrophy Therapy Meets Study Goal
View ArticleIonis Pharmaceuticals Inc. (IONS) Is Up Sharply On Phase 3 Study Results
Ionis Pharmaceuticals Inc. (IONS) Is Up Sharply On Phase 3 Study Results
View ArticleIonis Pharmaceuticals Inc. (IONS) Is Up Sharply On Phase 3 Study Results
Ionis Pharmaceuticals Inc. (IONS) Is Up Sharply On Phase 3 Study Results
View ArticleStocks Continue To Show A Lack Of Direction - U.S. Commentary
Stocks Continue To Show A Lack Of Direction - U.S. Commentary
View ArticleStocks Remain Little Changed In Mid-Day Trading - U.S. Commentary
Stocks Remain Little Changed In Mid-Day Trading - U.S. Commentary
View ArticleIonis Sees Further Upside After Initial Jump
Ionis Sees Further Upside After Initial Jump
View ArticleIonis Sees Further Upside After Initial Jump
Ionis Sees Further Upside After Initial Jump
View ArticleStocks Close Mixed For Fifth Consecutive Session - U.S. Commentary
Stocks Close Mixed For Fifth Consecutive Session - U.S. Commentary
View ArticleSMA Data Endears IONS To Investors, PFE Opens Wallet, Busy Months Ahead For DRRX
SMA Data Endears IONS To Investors, PFE Opens Wallet, Busy Months Ahead For DRRX
View ArticleStocks Showing A Lack Of Direction In Early Trading - U.S. Commentary
Stocks Showing A Lack Of Direction In Early Trading - U.S. Commentary
View ArticleStocks Showing A Lack Of Direction In Early Trading - U.S. Commentary
Stocks Showing A Lack Of Direction In Early Trading - U.S. Commentary
View ArticleStocks Showing A Lack Of Direction In Early Trading - U.S. Commentary
Stocks Showing A Lack Of Direction In Early Trading - U.S. Commentary
View ArticleStocks Showing A Lack Of Direction In Early Trading - U.S. Commentary
Stocks Showing A Lack Of Direction In Early Trading - U.S. Commentary
View ArticleStocks Showing A Lack Of Direction In Early Trading - U.S. Commentary
Stocks Showing A Lack Of Direction In Early Trading - U.S. Commentary
View ArticleStocks Showing A Lack Of Direction In Early Trading - U.S. Commentary
Stocks Showing A Lack Of Direction In Early Trading - U.S. Commentary
View ArticleStocks Pull Back Off Highs But Remain Mostly Positive - U.S. Commentary
Stocks Pull Back Off Highs But Remain Mostly Positive - U.S. Commentary
View ArticleStocks Continue To See Modest Strength In Mid-Day Trading - U.S. Commentary
Stocks Continue To See Modest Strength In Mid-Day Trading - U.S. Commentary
View ArticleStocks Close Slightly Higher Ahead Of BoJ, Fed Decisions - U.S. Commentary
Stocks Close Slightly Higher Ahead Of BoJ, Fed Decisions - U.S. Commentary
View ArticleBIIB To Face FDA, It's A Thumb Down For REGN, STJ Meets Trial Goal
BIIB To Face FDA, It's A Thumb Down For REGN, STJ Meets Trial Goal
View Article